Details for New Drug Application (NDA): 217081
✉ Email this page to a colleague
The generic ingredient in ATORVASTATIN CALCIUM is atorvastatin calcium. There are sixty-two drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the atorvastatin calcium profile page.
Summary for 217081
Tradename: | ATORVASTATIN CALCIUM |
Applicant: | Mankind Pharma |
Ingredient: | atorvastatin calcium |
Patents: | 0 |
Pharmacology for NDA: 217081
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for 217081
Suppliers and Packaging for NDA: 217081
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 217081 | ANDA | Lifestar Pharma LLC | 70756-247 | 70756-247-12 | 1000 TABLET, FILM COATED in 1 BOTTLE (70756-247-12) |
ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 217081 | ANDA | Lifestar Pharma LLC | 70756-247 | 70756-247-30 | 30 TABLET, FILM COATED in 1 BOTTLE (70756-247-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jan 5, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Jan 5, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 40MG BASE | ||||
Approval Date: | Jan 5, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription